Bittium Corporation’s Financial Calendar for the Year 2026

Bittium published its 2026 financial calendar: the Financial Statement Bulletin 2025 will be released 19 Feb 2026 (08:00 CET), the Half Year Financial Report (Jan–Jun 2026) on 7 Aug 2026 (08:00 CEST), and Business Reviews for Jan–Mar and Jan–Sep 2026 on 29 Apr and 29 Oct 2026 respectively, each preceded by a three‑week silent period. The Annual Report 2025 — including the Board report, Financial Statements 2025, a CSRD‑compliant sustainability report and Corporate Governance Statement — will be issued by 31 Mar 2026, and the AGM is scheduled for 22 Apr 2026. Bittium reported 2024 net sales of EUR 85.2m and operating profit of EUR 8.6m; the announcement is procedural and sets monitoring dates for potential stock‑moving disclosures but has low immediate market impact.

Analysis

Market structure: The calendar creates predictable, concentrated liquidity events (Financial Statement Bulletin 19 Feb 2026; Half‑Year 7 Aug 2026; Business Reviews 29 Apr & 29 Oct) that favor event‑driven and volatility strategies. Bittium (BITTI.HE) is a small‑cap (2024 sales €85.2m, operating profit €8.6m ≈10% margin) with thin free float — expect >20–40% implied‑volatility uplift in the 10 trading days ahead of releases and directional moves of ±15–30% on surprises. Cross‑asset impact is minimal (no sovereign bond or FX stress), though put/call skew on local Helsinki options will widen.

Risk assessment: Tail risks include a large contract cancellation (defence/secure comms), a cybersecurity disclosure, or CSRD sustainability liabilities revealed in the Annual Report (due by 31 Mar); each could cause >40% drawdowns. Immediate (days): volatility spikes and liquidity vacuum during silent periods; short term (weeks): price re‑rating on results/guidance; long term (quarters): revaluation if recurring medtech revenue or security contracts scale. Hidden dependency: revenue concentration on a few government/defence contracts and component supply chain timing that can materially shift near‑term guidance.

trade implications: Primary actionable plays are event vol and small cap directional positions sized to cap liquidity: buy ATM straddles 7–10 trading days before 19 Feb to capture IV jump (size 0.5–1% portfolio), or if fundamental upside expected, establish a 1–2% long equity position in BITTI.HE by Feb 10 with a 12% stop and 20–30% 3‑month target. Pair trade: long BITTI.HE 1.5% vs short NOKIA.HE 0.5% to express niche comms/ESG re‑rating vs large‑cap cyclicality; exit or rebalance after 29 Apr Business Review. If IV >45% consider selling iron condor 30–40% OTM to collect premium but cap risk with defined wings.

contrarian angles: Consensus will treat this as a routine calendar; that underprices the informational value of a CSRD‑grade sustainability report (could unlock ESG fund flows if KPIs are strong) and the Business Review cadence (April 29) which may disclose backlog/order wins. Reaction could be underdone if Bittium reports higher recurring medtech revenue — a 5–10% margin expansion could justify a 30–50% re‑rating over 12 months. Conversely, strong sustainability disclosures may expose near‑term capex needs and compress EPS; size positions modestly and use options to define downside.

Key Decisions for Investors

• Establish a tactical long position in Bittium (BITTI.HE) equal to 1–2% of portfolio by Feb 10, 2026 ahead of the Financial Statement Bulletin; set a hard stop‑loss at 12% and a profit target of 20–30% within 3 months (exit or trim at target).
• Buy a short‑dated ATM straddle on BITTI.HE expiring within 2–6 weeks after 19 Feb 2026 (enter ~10 trading days before release); allocate 0.5–1% portfolio risk to capture IV expansion and close within 2 trading days post‑print or if move >25%.
• Initiate a relative value pair: long BITTI.HE 1.5% vs short NOKIA.HE 0.5% (hedge ratio by beta) to express a small‑cap niche comms/ESG re‑rating view; hold through the 29 Apr 2026 Business Review and reassess—trim if underperformance exceeds 8%.
• If BITTI implied volatility exceeds 45% pre‑release, sell an iron‑condor 30–40% OTM (max loss defined) sized to collect premium equal to 0.25–0.5% portfolio risk; close positions at release or if underlying moves >20%.
• Monitor three specific filings: Annual Report (due by 31 Mar 2026) for CSRD disclosures (if scope 1–3 liabilities disclosed >€5m, reduce exposure immediately), Business Review on 29 Apr 2026 for order backlog metrics (if backlog growth >15% y/y, consider adding 0.5–1% exposure).